AstraZeneca, one of the world’s top COVID vaccine-producing enterprises, has of late been roasted for severe shortages of jabs across the European Union, with the criticism further escalating after the company’s announcements that it will be unable to fully make good on its delivery promises.
The European Union has kicked off legal proceedings against the Swedish-British pharmaceutical company AstraZeneca citing its failure to deliver on an agreed upon contract to deliver vaccines to EU countries, the European Commission said in a statement.
“The reason indeed being that the terms of the contract or some terms of the contract have not been respected and the company has not been in the position to come up with a reliable strategy to ensure timely delivery of doses”, Stefan De Keersmaecker, a spokesman for the European Commission, said on Monday.
Earlier, a diplomatic source was cited by the media as saying that the move was closely linked to the EU’s intention to ensure that all the projected deliveries take place in the second quarter of this year.
“EU states have to decide if they participate. It is about the fulfillment of deliveries by the end of the second quarter”, the person said.